Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome - Related Studies

Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome

This study is currently recruiting participants.

Study NCT00128180. Last updated on September 23, 2008. Information provided by University of New Mexico

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Hantavirus Infections

2	Additional conditions recognized in this trial
		Infection
		Syndrome

3	More general conditions related to this trial
		Bunyaviridae Infections
		Disease
		Pathologic Processes
		RNA Virus Infections
		Virus Diseases

4	Interventions listed in this trial
		Methylprednisolone
		Placebo

5	Additional drug interventions recognized in this trial
		Methylprednisolone acetate
		Methylprednisolone Hemisuccinate
		Prednisolone
		Prednisolone acetate

6	More general drug interventions related to this trial
		Anti-Inflammatory Agents
		Antiemetics
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Autonomic Agents
		Central Nervous System Agents
		Gastrointestinal Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Neuroprotective Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		University of New Mexico
		National Institute of Allergy and Infectious Diseases (NIAID)